India will be able to launch its vaccination campaign.

The country has authorized the use, "for emergency situations", of two vaccines against Covid-19, one developed by AstraZeneca and the University of Oxford and the other by the Indian pharmaceutical firm Bharat Biotech , announced Sunday, January 3 the local drug regulatory authority.

These two vaccines "are approved for restricted use in emergency situations," India's Comptroller General of Medicines, VG Somani, told a press conference. 

Prime Minister Narendra Modi estimated that this approval, according to an accelerated procedure, was "a decisive turning point to strengthen the spirit of combat" and to "accelerate the march towards a healthier Nation free from Covid".

India, with a population of 1.3 billion, is the second country most affected by the pandemic, with more than 10.3 million people who have been infected.

Nearly 150,000 people have died from Covid-19. 

Its rate of new infections has declined dramatically compared to September, when more than 90,000 cases were reported every day.

This green light should make it possible to kick off a vast vaccination campaign.

Simulation exercises have already been carried out nationally, and 96,000 health workers have been trained to administer the vaccine. 

VG Somani told reporters that the regulator "would never give approval if there was any security concern."

"These vaccines are 100% safe," he continued, adding that the observed side effects, such as "mild fever, pain and allergies were common to all vaccines."

Happy new year, everyone!

All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off.

COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks.

pic.twitter.com/TcKh4bZIKK

- Adar Poonawalla (@adarpoonawalla) January 3, 2021

The Serum Institute in India, the world's largest vaccine producer, said it manufactures between 50 and 60 million doses of AstraZeneca vaccine each month.

Its chief executive Adar Poonawalla tweeted after the green light was announced that the vaccine would be "ready for distribution in the coming weeks."

With AFP

The summary of

France 24

week

invites you to come back to the news that marked the week

I subscribe

Take international news everywhere with you!

Download the France 24 application

google-play-badge_FR